Cytoplasmic Reticular (Mitochondrial) Pattern (Cyto. Reticular MITO) in Immunofluorescence Testing
The Cytoplasmic Reticular (MITO) pattern is an immunofluorescence staining pattern observed in indirect immunofluorescence assays (IFA), particularly in Antinuclear Antibody (ANA) testing. This pattern indicates the presence of autoantibodies targeting mitochondrial structures, leading to a distinct reticular (net-like) cytoplasmic fluorescence.
Key Features of the Cytoplasmic Reticular (MITO) Pattern
-
Mitochondrial Localization
- This pattern is associated with autoantibodies binding to mitochondrial proteins, often seen in Primary Biliary Cholangitis (PBC) and other autoimmune liver diseases.
-
Immunofluorescence Appearance
- The staining appears as a fine, net-like (reticular) fluorescence across the cytoplasm, reflecting the distribution of mitochondria within cells.
-
Associated Autoantibodies
- Anti-Mitochondrial Antibodies (AMA), particularly the AMA-M2 subtype, are strongly linked to this pattern.
- AMA-M2 targets components of the pyruvate dehydrogenase complex (PDC-E2) in the inner mitochondrial membrane.
Clinical Associations
The Cytoplasmic Reticular (MITO) pattern is most commonly associated with:
- Primary Biliary Cholangitis (PBC) – A chronic autoimmune liver disease affecting intrahepatic bile ducts.
- Autoimmune Hepatitis (AIH) – Occasionally present in overlap syndromes with PBC.
- Systemic Autoimmune Diseases – Rarely seen in connective tissue diseases or chronic infections.
Diagnostic Considerations
-
Positive Cytoplasmic Reticular (MITO) pattern in an ANA test should prompt further evaluation, including:
- Anti-Mitochondrial Antibody (AMA) testing
- Liver function tests (LFTs)
- Additional autoimmune markers
-
Since ANA testing primarily detects nuclear antibodies, a cytoplasmic staining pattern suggests the need for broader autoimmune screening to confirm clinical significance.
Conclusion
A Cytoplasmic Reticular (MITO) pattern in immunofluorescence testing is a significant finding, often indicating anti-mitochondrial antibodies (AMA) and associated with autoimmune liver disease, particularly PBC. Further clinical and laboratory evaluation is essential to determine its diagnostic relevance.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.